Stada and Mylan targeting Bristol-Myers Squibb’s Upsa (€1bn)

Stada and Mylan targeting Bristol-Myers Squibb’s Upsa (€1bn)

Source: 
GoinPharma
snippet: 

Germany-based generics producer Stada is reportedly targeting French OTC manufacturer Upsa, owned by Bristol-Myers Squibb.